Clinical Trials

An Exploratory Phase 1b Open-label Multi-arm Trial to Evaluate the Safety and Efficacy of CC-90009 in Combination with Anti-Leukemia Agents in Subjects with Acute Myeloid Leukemia


Study ID
CC-90009-AML-002

NCT Number
NCT04336982 (Click on the NCT number for more information about the trial)

Research Study Number
20200447

Principle Investigator
Dr. Koprivinikar, Jamie

Phase
I

Sponsor
Celgene Corporation


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now